Your browser doesn't support javascript.
loading
The real-world observational prospective study of health outcomes with dulaglutide and liraglutide in patients with type 2 diabetes (TROPHIES): Final, 24-month analysis of time to first significant treatment change, treatment persistence and clinical outcomes.
Giorgino, Francesco; Guerci, Bruno; Füchtenbusch, Martin; Lebrec, Jérémie; Boye, Kristina; Orsini Federici, Marco; Heitmann, Elke; Dib, Anne; Yu, Maria; Sapin, Hélène; García-Pérez, Luis-Emilio.
Afiliação
  • Giorgino F; University of Bari Aldo Moro, Bari, Italy.
  • Guerci B; University Hospital of Nancy, Vandoeuvre Lès Nancy, France.
  • Füchtenbusch M; Marienplatz Diabetes Center, Munich, Germany.
  • Lebrec J; HaaPACS GmbH, Schriesheim, Germany.
  • Boye K; Lilly Corporate Center, Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Orsini Federici M; Lilly Corporate Center, Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Heitmann E; Lilly Corporate Center, Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Dib A; Lilly Corporate Center, Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Yu M; Lilly Corporate Center, Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Sapin H; Lilly Corporate Center, Eli Lilly and Company, Indianapolis, Indiana, USA.
  • García-Pérez LE; Lilly Corporate Center, Eli Lilly and Company, Indianapolis, Indiana, USA.
Diabetes Obes Metab ; 25(12): 3465-3477, 2023 12.
Article em En | MEDLINE | ID: mdl-37700627

Texto completo: 1 Eixos temáticos: Pesquisa_clinica Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 Tipo de estudo: Observational_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Eixos temáticos: Pesquisa_clinica Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 Tipo de estudo: Observational_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article